Literature DB >> 15378585

Nitric oxide modulation of early angiogenesis.

J Scott Isenberg1.   

Abstract

Angiogenesis is the process of new vessel formation from an existing vasculature network. In all but a few circumstances it is tightly controlled and suppressed. Precise understanding of the factors involved in modulation of angiogenesis has significant potential clinical value. One agent believed to play a role in angiogenesis is nitric oxide. However, there remain substantial uncertainties concerning the specifics of this role. The present study was undertaken to better define the role nitric oxide plays in angiogenesis associated with acute wound healing. Muscle biopsies from the pectoralis major of C57B6 mice were embedded in 500 microl of type I collagen matrix, and incubated in the presence of growth medium for 14 days. Treatment wells received L-Arginine (2 mM), L-NAME (300 microM), or SNAP (10-20 microM). Angiogenic response was quantified as the measure of cell migration through the matrix and as the total cells recovered from the matrix. Whole lung specimens and aortic segments served as sources of endothelial and vascular smooth muscle cells respectively for proliferation studies under similar treatment conditions. Nitric oxide was found to exert either a stimulatory or inhibitory effect on angiogenesis and cell proliferation that was subject to the assay system and specific vascular cell types present. These results suggest that the role of nitric oxide in angiogenesis is context dependent. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378585     DOI: 10.1002/micr.20051

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  8 in total

1.  Angiogenesis effect of therapeutic ultrasound on HUVECs through activation of the PI3K-Akt-eNOS signal pathway.

Authors:  Jing-Juan Huang; Yi-Qin Shi; Rui-Lin Li; An Hu; Zhao-Yang Lu; Liang Weng; Shen-Qi Wang; Yi-Peng Han; Lan Zhang; Bao Li; Chang-Ning Hao; Jun-Li Duan
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  CD151 gene delivery activates PI3K/Akt pathway and promotes neovascularization after myocardial infarction in rats.

Authors:  Zhenzhong Zheng; Zhengxiang Liu
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

3.  Nitric oxide effects on the function of aged cells ex vivo and in vivo.

Authors:  May J Reed; Daniel Eyman; Nathan Karres
Journal:  In Vivo       Date:  2008 Nov-Dec       Impact factor: 2.155

4.  Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.

Authors:  Jeff S Isenberg; Loretta K Pappan; Martin J Romeo; Mones Abu-Asab; Maria Tsokos; David A Wink; William A Frazier; David D Roberts
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

5.  Bacillus Calmette Guerin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model.

Authors:  Catalina Lodillinsky; Yanina Langle; Ariel Guionet; Adrián Góngora; Alberto Baldi; Eduardo O Sandes; Alberto Casabé; Ana María Eiján
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

6.  Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.

Authors:  Jeff S Isenberg; Sruti Shiva; Mark Gladwin
Journal:  Nitric Oxide       Date:  2009-05-27       Impact factor: 4.427

7.  TLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathways.

Authors:  Ulka Sachdev; Xiangdong Cui; Ryan McEnaney; Tian Wang; Kelly Benabou; Edith Tzeng
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

8.  Green Synthesis of Silver Nanoparticles by the Cyanobacteria Synechocystis sp.: Characterization, Antimicrobial and Diabetic Wound-Healing Actions.

Authors:  Nancy S Younis; Maged E Mohamed; Nermin A El Semary
Journal:  Mar Drugs       Date:  2022-01-06       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.